BEDFORD, Mass., Jan. 20, 2015 /PRNewswire/ -- Hologic, Inc. (NASDAQ: HOLX) today announced two additions to its executive leadership team. John Griffin will join the Company as general counsel, and Allison (Ali) Bebo as senior vice president, human resources.
"We are excited that John and Ali have agreed to join Hologic to round out and complete a transformation of our leadership team," said Steve MacMillan, the Company's president and chief executive officer. "I am confident that we now have the right team in place to continue building a company focused on sustainable, organic growth."
Both appointments are effective on February 2, 2015.
About John Griffin
John Griffin is a seasoned executive with nearly 30 years of experience across a broad spectrum of legal matters. He spent 15 years in positions of increasing responsibility at Covidien, most recently serving as vice president and deputy general counsel, where he managed all litigation matters and compliance programs. Before joining Covidien, he served as an assistant US attorney for the District of Massachusetts. He began his legal career at Nutter, McClennen & Fish in Boston. He has a JD from Harvard Law School and a BA in political science from Columbia University.
About Ali Bebo
Ali Bebo is a proven business leader with extensive human resources experience and a demonstrated track record of delivering results. She worked for ANN INC. for 20 years in positions of increasing responsibility, mainly in talent management and organizational development. Most recently she served as vice president, talent management. In this position, she was responsible for enterprise-wide talent management and workplace engagement strategies. She has a BA in political science from the University of California, Los Angeles.
About Hologic, Inc.
Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products. The Company's core business units focus on diagnostics, breast health, GYN surgical, and skeletal health. With a unified suite of technologies and a robust research and development program, Hologic is dedicated to The Science of Sure. For more information on Hologic, visit www.hologic.com.
This press release contains forward-looking information that involves risks and uncertainties, including statements about sustainable organic growth and the ability to attract and retain qualified executives. These forward-looking statements are based upon assumptions made by the Company as of the date hereof and are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those anticipated. Actual results may differ from those indicated as a result of risks and uncertainties, including, without limitation, the risks and uncertainties described from time to time in the filings made by the Company with the Securities and Exchange Commission (SEC). The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements presented herein to reflect any change in expectations or any change in events, conditions or circumstances on which any such statements are based. For more information regarding risks and uncertainties associated with the Company's business, please refer to the Company's filings with the SEC, including the Annual Report on Form 10-K for the fiscal year ended September 27, 2014 filed by the Company with the SEC on November 20, 2014.
Vice president, investor relations and
SOURCE Hologic, Inc.